NCT02108028: Study of Voicing My CHOiCES as a Tool for Advanced Care Planning in Young Adults With Cancer

Breast Cancer Type: HER2+, HR+ & HER2-negative, Triple Negative
Hormone Mutations: ER+, PR+
Other Mutations: 
Breast Cancer Tissue: 
Recruitment Status: Recruiting

Drug Category: Other

Key Eligibility Criteria:

Gender: All
Age: 18 Years and older (Adult, Older Adult)
Location of Metastases: 
Additional Notes: Patients must be between the ages of 18-39; Patients must be enrolled on an NIH protocol or treated at a participating site

Comments are closed.

Up ↑